|
English
|
正體中文
|
简体中文
|
总笔数 :2856655
|
|
造访人次 :
53548372
在线人数 :
1398
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"young sun"的相关文件
显示项目 1-3 / 3 (共1页)
1
每页显示[10|25|50]项目
| 國立成功大學 |
2024-11 |
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 tri
|
Boku;Narikazu;Omori;Takeshi;Shitara;Kohei;Sakuramoto;Shinichi;Yamaguchi;Kensei;Kato;Ken;Kadowaki;Shigenori;Tsuji;Kunihiro;Ryu;Min-Hee;Oh;Do-Youn;Oh;Cheul, Sang;Rha;Young, Sun;Lee;Keun-Wook;Chung;Ik-Joo;Sym;Jin, Sun;Chen;Li-Tzong;Chen;Jen-Shi;Bai;Li-Yuan;Nakada;Takashi;Hagihara;Shunsuke;Makino;Reina;Nishiyama;Eiji;Kang;Yoon-Koo |
| 國立成功大學 |
2024-08 |
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, pl
|
Kang;Yoon-Koo;Terashima;Masanori;Kim;Young-Woo;Boku;Narikazu;Chung;Cheol, Hyun;Chen;Jen-Shi;Ji;Jiafu;Yeh;Ta-Sen;Chen;Li-Tzong;Ryu;Min-Hee;Kim;Gwang, Jong;Omori;Takeshi;Rha;Young, Sun;Kim;Yong, Tae;Ryu;Won, Keun;Sakuramoto;Shinichi;Nishida;Yasunori;Fukushima;Norimasa;Yamada;Takanobu;Bai;Li-Yuan;Hirashima;Yoshinori;Hagihara;Shunsuke;Nakada;Takashi;Sasako;Mitsuru |
| 國立成功大學 |
2024-06-1 |
Neoadjuvant/adjuvant pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: Major pathologic response (mPR) in KEYNOTE-585
|
Shitara;Kohei;Bang;Yung-Jue;Wyrwicz;Lucjan, S.;Rha;Young, Sun;Oshima;Takashi;Bartolomeo, Di;Maria;Park;Young-Kyu;Lonardi;Sara;Weber;Yanez, Patricio Eduardo;Yen;Chia-Jui;Metges;Jean-Philippe;Garrido;Marcelo;Moehler;Markus, H.;Pelles-Avraham;Sharon;Yong;Wei-Peng;Spallanzani;Andrea;Jensen;Erin;Krishnan;Radha;Shih;Chie-Schin;Al-Batran;Salah-Eddin |
显示项目 1-3 / 3 (共1页)
1
每页显示[10|25|50]项目
|
